Kimberly-Clark vs. Clorox: The Higher Yield May Not Be the Better Dividend

Impact · against what's priced in

The article provides no catalysts for KMB or CLX as the risks to their respective dividends—China disinformation for KMB and debt/inflation for CLX—are already fully absorbed by current valuations. The market continues to reject Clorox's growth forecasts and Kimberly-Clark's synergy targets regardless of these reported headwinds.

KMB−0.10

Already priced in

The price assumes

A recovery in China diaper volumes following the Huggies contamination scare